FormFactor Inc. FormFactor Inc. Common Stock vs QXO Inc. Common Stock — how do they compare? FormFactor Inc. FormFactor Inc. Common Stock trades at $117.22 (market cap $10.01B), while QXO Inc. Common Stock trades at $10.35 (market cap $11.43B). The key difference: FormFactor Inc. FormFactor Inc. Common Stock and QXO Inc. Common Stock are close in size by market cap, and FormFactor Inc. FormFactor Inc. Common Stock is trading nearer its 52-week high, QXO Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold FormFactor Inc. FormFactor Inc. Common Stock for 6 Days and QXO Inc. Common Stock for 0 Days on average.
| FORM | QXO | |
|---|---|---|
Market Cap | $10.01B | $11.43B |
Volume | 1,445,909 | 21,645,941 |
Sector | Technology | Industrials |
52-Week High | $159.93 | $27.07 |
52-Week Low | $41.29 | $10.33 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $9.69B | $16.75B |
Signals from Pluang's Aura AI — not financial advice
FormFactor (FORM) trades at $128.09, down 1.68% on the day, amid a bullish technical setup with key support at $127. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 28. Revenue and net income are projected to grow significantly in 2026, though valuation ratios remain elevated.
The outlook is positive, driven by strong AI-driven semiconductor demand and strategic collaborations, but high P/E and P/S ratios pose valuation risks. Analyst consensus is bullish with a $154.71 price target, though insider selling and negative cash flow in 2025 warrant caution.
QXO trades at $11.02, up 3.57% on the day but down significantly year-to-date amid weak residential demand and integration challenges from its TopBuild acquisition. The stock shows neutral technical signals with support near $10-$11 and resistance at $12. Fundamentally, revenue grew to $6.84B in 2025 but net losses deepened to $279.4M, with a negative profit margin of -5.17% in 2026. Analyst sentiment remains bullish with a $22.89 consensus target, though recent news highlights margin pressure and execution risks.
The outlook hinges on successful integration of acquisitions and EBITDA growth targets, but high execution risk, negative earnings, and sector headwinds pose substantial downside. With 100% buy ratings from analysts and institutional accumulation, patient investors may see upside if management delivers on its playbook, though volatility is expected near-term.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
FormFactor, Inc. provides semiconductor test and measurement technologies used across the integrated circuit lifecycle, manufacturing probe cards and analytical probes through its Probe Cards segment and probe stations, thermal systems, and cryogenic systems through its Systems segment.
Read more on FORM →QXO, Inc. is a distributor of roofing, insulation, waterproofing, and other building materials, serving contractors and builders across US and Canada through its network of branch locations.
Read more on QXO →